• by bcarlson@marketresearch.com
  • October 23 2014


Consortium Amplifies miRNA Development

Consortium Amplifies miRNA Development

In our miRNA market research report, we detail some of the developments and research efforts in this promising area of medicine.  A data management organization, the RNAcentral Consortium, now offers the website RNAcentral (http://rnacentral.org) to serve as a unified resource for all types of noncoding RNA data. It was developed by pooling information from a variety of sources, including databases and tools for browsing, contains approximately 8 million sequences. By combining databases from different sources, it allows users the ability to explore different RNA sequences according to source, species, and molecular function. It is anticipated that further options will be made available in the future.

There is great interest currently in the use of miRNAs as biomarkers for cancer and other diseases, given their involvement in cancer initiation, progression, migration, invasion and metastasis. Large data bases offer the opportunity to search out and evaluate large numbers of sequences. The detection of these sequences in plasma of breast cancer patients may provide new biomarkers for a number of different cancers, with the potential to develop and introduce novel and non-invasive screening tests.